Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 92

1.

The demographic and clinical characteristics of an Italian population of adult outpatients with chronic cough.

Campi G, Noale M, Fabbrizzi A, Lavorini F, Maggi S, Fontana G.

Aging Clin Exp Res. 2020 Jan 16. doi: 10.1007/s40520-019-01464-4. [Epub ahead of print]

PMID:
31950437
2.

Spacers and Valved Holding Chambers - the risk of switching to different chambers.

Lavorini F, Barreto C, van Boven JFM, Carroll W, Conway J, Costello R, Dahl BH, Dekhuijzen RPN, Holmes S, Levy M, Molimard M, Roche N, Román-Rodriguez M, Scichilone N, Scullion J, Usmani OS.

J Allergy Clin Immunol Pract. 2020 Jan 9. pii: S2213-2198(20)30033-7. doi: 10.1016/j.jaip.2019.12.035. [Epub ahead of print]

PMID:
31927099
3.

What to consider before prescribing inhaled medications: a pragmatic approach for evaluating the current inhaler landscape.

Lavorini F, Janson C, Braido F, Stratelis G, Løkke A.

Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619884532. doi: 10.1177/1753466619884532.

4.

A multinational observational study identifying primary care patients at risk of overestimation of asthma control.

Kritikos V, Price D, Papi A, Infantino A, Ställberg B, Ryan D, Lavorini F, Chrystyn H, Haughney J, Lisspers K, Gruffydd-Jones K, Román Rodríguez M, Høegh Henrichsen S, van der Molen T, Carter V, Bosnic-Anticevich S.

NPJ Prim Care Respir Med. 2019 Dec 5;29(1):43. doi: 10.1038/s41533-019-0156-4.

5.

100 Years of Drug Delivery to the Lungs.

Lavorini F, Buttini F, Usmani OS.

Handb Exp Pharmacol. 2019;260:143-159. doi: 10.1007/164_2019_335. Review.

PMID:
31792683
6.

The lung microbiome: clinical and therapeutic implications.

Fabbrizzi A, Amedei A, Lavorini F, Renda T, Fontana G.

Intern Emerg Med. 2019 Nov;14(8):1241-1250. doi: 10.1007/s11739-019-02208-y. Epub 2019 Oct 31. Review.

PMID:
31667699
7.

Understanding Dry Powder Inhalers: Key Technical and Patient Preference Attributes.

Levy ML, Carroll W, Izquierdo Alonso JL, Keller C, Lavorini F, Lehtimäki L.

Adv Ther. 2019 Oct;36(10):2547-2557. doi: 10.1007/s12325-019-01066-6. Epub 2019 Sep 2.

8.

Concomitant bilastine and montelukast as additive therapy for seasonal allergic rhinoconjunctivits and mild-to-moderate asthma. The SKY study.

Lavorini F, Matucci A, Rossi O, Pistolesi M; SKY study investigators.

Allergy. 2019 Aug 2. doi: 10.1111/all.14007. [Epub ahead of print] No abstract available.

PMID:
31376160
9.

Easyhaler®: an overview of an inhaler device for day-to-day use in patients with asthma and chronic obstructive pulmonary disease.

Lavorini F.

Drugs Context. 2019 Jun 5;8:212596. doi: 10.7573/dic.212596. eCollection 2019. Review.

10.

Spirometric assessment of emphysema presence and severity as measured by quantitative CT and CT-based radiomics in COPD.

Occhipinti M, Paoletti M, Bartholmai BJ, Rajagopalan S, Karwoski RA, Nardi C, Inchingolo R, Larici AR, Camiciottoli G, Lavorini F, Colagrande S, Brusasco V, Pistolesi M.

Respir Res. 2019 May 23;20(1):101. doi: 10.1186/s12931-019-1049-3.

11.

The pathogenetic mechanisms of cough in idiopathic pulmonary fibrosis.

Bargagli E, Di Masi M, Perruzza M, Vietri L, Bergantini L, Torricelli E, Biadene G, Fontana G, Lavorini F.

Intern Emerg Med. 2019 Jan;14(1):39-43. doi: 10.1007/s11739-018-1960-5. Epub 2018 Sep 29. Review.

PMID:
30269188
12.

Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study.

Price DB, Thomas V, Richard Dekhuijzen PN, Bosnic-Anticevich S, Roche N, Lavorini F, Raju P, Freeman D, Nicholls C, Small IR, Sims E, Safioti G, Canvin J, Chrystyn H.

BMC Pulm Med. 2018 Jun 28;18(1):107. doi: 10.1186/s12890-018-0665-x.

13.

Inhalation therapy in the next decade: Determinants of adherence to treatment in asthma and COPD.

Donner CF, Amaducci S, Bacci E, Baldacci S, Bartoli ML, Beghi GM, Benfante A, Brighindi S, Casali L, Castiglia D, Cazzola M, Celi A, Cianchetti S, Colombo G, Crimi C, Dente FL, Di Maria G, Di Maria A, Latorre M, Lavorini F, Maio S, Mannini C, Messina R, Paggiaro PL, Pignatti P, Price D, Scichilone N, Simoni M, Spanevello A, Stagno d'Alcontres M, Tan S, Torchio R, Viegi G, Visca D, Wouters EFM, Yu Hui Xin S.

Monaldi Arch Chest Dis. 2018 Feb 2;88(1):886. doi: 10.4081/monaldi.2018.886.

14.

Addressing the Impact and Unmet Needs of Nonadherence in Asthma and Chronic Obstructive Pulmonary Disease: Where Do We Go From Here?

Dekhuijzen R, Lavorini F, Usmani OS, van Boven JFM.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):785-793. doi: 10.1016/j.jaip.2017.11.027. Epub 2018 Jan 12. Review.

15.

Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes.

Usmani OS, Lavorini F, Marshall J, Dunlop WCN, Heron L, Farrington E, Dekhuijzen R.

Respir Res. 2018 Jan 16;19(1):10. doi: 10.1186/s12931-017-0710-y. Review.

16.

Gorham-Stout Disease Management during Pregnancy.

Bargagli E, Piccioli C, Cavigli E, Scola M, Rosi E, Lavorini F, Novelli L, Ugolini D, Notaristefano T, Filippo P, Miele V, Comin CE, Pistolesi M, Voltolini L.

AJP Rep. 2017 Oct;7(4):e226-e229. doi: 10.1055/s-0037-1615259. Epub 2017 Dec 19.

17.

Increased Risk of Atherosclerosis in Patients with Sarcoidosis.

Bargagli E, Rosi E, Pistolesi M, Lavorini F, Voltolini L, Rottoli P.

Pathobiology. 2017;84(5):258-263. doi: 10.1159/000477736. Epub 2017 Aug 10. Review.

18.

Pulmonary hypertension nosography: are all patients classifiable?

Torricelli E, Occhipinti M, Lavorini F, Cresci C, Arcangeli C, Cavigli E, Bigazzi F, Pistolesi M.

Intern Emerg Med. 2018 Jan;13(1):35-40. doi: 10.1007/s11739-017-1700-2. Epub 2017 Jun 30. No abstract available.

PMID:
28667478
19.

Erratum to: Recent advances in capsule-based dry powder inhaler technology.

Lavorini F, Pistolesi M, Usmani OS.

Multidiscip Respir Med. 2017 Jun 23;12:19. doi: 10.1186/s40248-017-0100-9. eCollection 2017.

20.

Trace metals in fluids lining the respiratory system of patients with idiopathic pulmonary fibrosis and diffuse lung diseases.

Bargagli E, Lavorini F, Pistolesi M, Rosi E, Prasse A, Rota E, Voltolini L.

J Trace Elem Med Biol. 2017 Jul;42:39-44. doi: 10.1016/j.jtemb.2017.04.001. Epub 2017 Apr 5. Review.

PMID:
28595790
21.

A 57-year-old chronic cougher with somatically evoked cough.

Lavorini F, Fontana GA.

Pulm Pharmacol Ther. 2017 Dec;47:56-58. doi: 10.1016/j.pupt.2017.05.014. Epub 2017 May 28. No abstract available.

PMID:
28564586
22.

Recent advances in capsule-based dry powder inhaler technology.

Lavorini F, Pistolesi M, Usmani OS.

Multidiscip Respir Med. 2017 May 22;12:11. doi: 10.1186/s40248-017-0092-5. eCollection 2017. Review. Erratum in: Multidiscip Respir Med. 2017 Jun 23;12 :19.

23.

Urging Europe to put non-adherence to inhaled respiratory medication higher on the policy agenda: a report from the First European Congress on Adherence to Therapy.

van Boven JFM, Lavorini F, Dekhuijzen PNR, Blasi F, Price DB, Viegi G.

Eur Respir J. 2017 May 19;49(5). pii: 1700076. doi: 10.1183/13993003.00076-2017. Print 2017 May. No abstract available.

24.

Inhaler technique mastery and maintenance in healthcare professionals trained on different devices.

Bosnic-Anticevich S, Callan C, Chrystyn H, Lavorini F, Nikolaou V, Kritikos V, Dekhuijzen PNR, Roche N, Bjermer L, Rand C, Zwar N, Price DB.

J Asthma. 2018 Jan;55(1):79-88. doi: 10.1080/02770903.2017.1310227. Epub 2017 Apr 28.

PMID:
28332886
25.

Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma Outcomes.

Price DB, Román-Rodríguez M, McQueen RB, Bosnic-Anticevich S, Carter V, Gruffydd-Jones K, Haughney J, Henrichsen S, Hutton C, Infantino A, Lavorini F, Law LM, Lisspers K, Papi A, Ryan D, Ställberg B, van der Molen T, Chrystyn H.

J Allergy Clin Immunol Pract. 2017 Jul - Aug;5(4):1071-1081.e9. doi: 10.1016/j.jaip.2017.01.004. Epub 2017 Mar 9.

PMID:
28286157
26.

Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations.

Scichilone N, Braido F, Lavorini F, Levy ML, Usmani OS.

Drugs Aging. 2017 May;34(5):321-330. doi: 10.1007/s40266-017-0449-7. Review.

27.

A Randomized Clinical Trial Comparing the Effects of Antitussive Agents on Respiratory Center Output in Patients With Chronic Cough.

Mannini C, Lavorini F, Zanasi A, Saibene F, Lanata L, Fontana G.

Chest. 2017 Jun;151(6):1288-1294. doi: 10.1016/j.chest.2017.02.001. Epub 2017 Feb 10.

PMID:
28192113
28.

The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes.

Bosnic-Anticevich S, Chrystyn H, Costello RW, Dolovich MB, Fletcher MJ, Lavorini F, Rodríguez-Roisin R, Ryan D, Wan Yau Ming S, Price DB.

Int J Chron Obstruct Pulmon Dis. 2016 Dec 21;12:59-71. doi: 10.2147/COPD.S117196. eCollection 2017. Erratum in: Int J Chron Obstruct Pulmon Dis. 2019 Aug 02;14:1739.

29.

Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN).

Braido F, Scichilone N, Lavorini F, Usmani OS, Dubuske L, Boulet LP, Mosges R, Nunes C, Sánchez-Borges M, Ansotegui IJ, Ebisawa M, Levi-Schaffer F, Rosenwasser LJ, Bousquet J, Zuberbier T, Canonica GW; Interasma Executive Board; WAO Board of Directors; ARIA; GA²LEN.

Asthma Res Pract. 2016 Oct 28;2:12. eCollection 2016.

30.

Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN).

Braido F, Scichilone N, Lavorini F, Usmani OS, Dubuske L, Boulet LP, Mosges R, Nunes C, Sanchez-Borges M, Ansotegui IJ, Ebisawa M, Levi-Schaffer F, Rosenwasser LJ, Bousquet J, Zuberbier T, Canonica GW, Cruz A, Yanez A, Yorgancioglu A, Deleanu D, Rodrigo G, Berstein J, Ohta K, Vichyanond P, Pawankar R, Gonzalez-Diaz SN, Nakajima S, Slavyanskaya T, Fink-Wagner A, Loyola CB, Ryan D, Passalacqua G, Celedon J, Ivancevich JC, Dobashi K, Zernotti M, Akdis M, Benjaponpitak S, Bonini S, Burks W, Caraballo L, El-Sayed ZA, Fineman S, Greenberger P, Hossny E, Ortega-Martell JA, Saito H, Tang M, Zhang L; for Interasma Executive Board; ARIA; GA2LEN.

World Allergy Organ J. 2016 Oct 28;9(1):37. eCollection 2016.

31.

Patients' perspectives and preferences in the choice of inhalers: the case for Respimat(®) or HandiHaler(®).

Dekhuijzen PN, Lavorini F, Usmani OS.

Patient Prefer Adherence. 2016 Aug 18;10:1561-72. doi: 10.2147/PPA.S82857. eCollection 2016. Review.

32.

Antitussive effect of carcainium chloride in patients with chronic cough and idiopathic interstitial pneumonias: A pilot study.

Lavorini F, Spina D, Walker MJ, Franciosi L, Page CP, Fontana GA.

Pulm Pharmacol Ther. 2016 Oct;40:91-4. doi: 10.1016/j.pupt.2016.08.001. Epub 2016 Aug 15.

PMID:
27538683
33.

Dilemmas, Confusion, and Misconceptions Related to Small Airways Directed Therapy.

Lavorini F, Pedersen S, Usmani OS; Aerosol Drug Management Improvement Team (ADMIT).

Chest. 2017 Jun;151(6):1345-1355. doi: 10.1016/j.chest.2016.07.035. Epub 2016 Aug 11. Review.

34.

Erratum: Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT).

Levy ML, Dekhuijzen P, Barnes PJ, Broeders M, Corrigan CJ, Chawes BL, Corbetta L, Dubus JC, Hausen T, Lavorini F, Roche N, Sanchis J, Usmani OS, Viejo J, Vincken W, Voshaar T, Crompton GK, Pedersen S.

NPJ Prim Care Respir Med. 2016 May 26;26:16028. doi: 10.1038/npjpcrm.2016.28. eCollection 2016.

35.

Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices.

Lavorini F, Mannini C, Chellini E, Fontana GA.

Drugs Aging. 2016 Jul;33(7):461-73. doi: 10.1007/s40266-016-0377-y. Review.

PMID:
27216613
36.

Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT).

Levy ML, Dekhuijzen PN, Barnes PJ, Broeders M, Corrigan CJ, Chawes BL, Corbetta L, Dubus JC, Hausen T, Lavorini F, Roche N, Sanchis J, Usmani OS, Viejo J, Vincken W, Voshaar T, Crompton GK, Pedersen S.

NPJ Prim Care Respir Med. 2016 Apr 21;26:16017. doi: 10.1038/npjpcrm.2016.17. Review. Erratum in: NPJ Prim Care Respir Med. 2016 May 26;26:16028.

37.

The Clinical Value of Deflation Cough in Chronic Coughers With Reflux Symptoms.

Lavorini F, Chellini E, Bigazzi F, Surrenti E, Fontana GA.

Chest. 2016 Jun;149(6):1467-72. doi: 10.1016/j.chest.2016.01.008. Epub 2016 Jan 22.

PMID:
26836929
38.

Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting.

Westerik JA, Carter V, Chrystyn H, Burden A, Thompson SL, Ryan D, Gruffydd-Jones K, Haughney J, Roche N, Lavorini F, Papi A, Infantino A, Roman-Rodriguez M, Bosnic-Anticevich S, Lisspers K, Ställberg B, Henrichsen SH, van der Molen T, Hutton C, Price DB.

J Asthma. 2016;53(3):321-9. doi: 10.3109/02770903.2015.1099160. Epub 2016 Jan 26.

39.

Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study.

Chrystyn H, Price DB, Molimard M, Haughney J, Bosnic-Anticevich S, Lavorini F, Efthimiou J, Shan D, Sims E, Burden A, Hutton C, Roche N.

BMC Pulm Med. 2016 Jan 14;16:12. doi: 10.1186/s12890-016-0169-5.

40.

Switching treatments in COPD: implications for costs and treatment adherence.

Braido F, Lavorini F, Blasi F, Baiardini I, Canonica GW.

Int J Chron Obstruct Pulmon Dis. 2015 Dec 3;10:2601-8. doi: 10.2147/COPD.S79635. eCollection 2015. Review.

41.

Erratum to: Safety Considerations of Inhaled Corticosteroids in the Elderly.

Battaglia S, Cardillo I, Lavorini F, Spatafora M, Scichilone N.

Drugs Aging. 2015 Dec;32(12):1067-76. doi: 10.1007/s40266-015-0320-7.

PMID:
26578157
42.

Asthma and COPD: Interchangeable use of inhalers. A document of Italian Society of Allergy, Asthma and Clinical Immmunology (SIAAIC) & Italian Society of Respiratory Medicine (SIMeR).

Lavorini F, Braido F, Baiardini I, Blasi F, Canonica GW; SIAAC-SIMER.

Pulm Pharmacol Ther. 2015 Oct;34:25-30. doi: 10.1016/j.pupt.2015.07.005. Epub 2015 Jul 22. Review.

PMID:
26209820
43.

Effect of an anti-reflux medical device in the control of deflation cough: A placebo-controlled comparative study with an antacid drug in chronic coughers.

Chellini E, Lavorini F, Campi G, Mannini C, Fontana GA.

Pulm Pharmacol Ther. 2015 Aug;33:11-4. doi: 10.1016/j.pupt.2015.05.002. Epub 2015 May 15.

PMID:
25986314
44.

A crossover randomized comparative study of zofenopril and ramipril on cough reflex and airway inflammation in healthy volunteers.

Lavorini F, Chellini E, Innocenti M, Campi G, Egan CG, Mogavero S, Fontana GA.

Cough. 2014 Dec 24;10(1):7. doi: 10.1186/s12997-014-0007-5. eCollection 2014.

45.

Inhaled drug delivery in the hands of the patient.

Lavorini F.

J Aerosol Med Pulm Drug Deliv. 2014 Dec;27(6):414-8. doi: 10.1089/jamp.2014.1132. Review.

PMID:
25238005
46.

Safety considerations of inhaled corticosteroids in the elderly.

Battaglia S, Cardillo I, Lavorini F, Spatafora M, Scichilone N.

Drugs Aging. 2014 Nov;31(11):787-96. doi: 10.1007/s40266-014-0213-1. Review. Erratum in: Drugs Aging. 2015 Dec;32(12):1067-76.

PMID:
25212953
47.

Small changes in lung function in runners with marathon-induced interstitial lung edema.

Zavorsky GS, Milne EN, Lavorini F, Rienzi JP, Cutrufello PT, Kumar SS, Pistolesi M.

Physiol Rep. 2014 Jun 27;2(6). pii: e12056. doi: 10.14814/phy2.12056. Print 2014 Jun 1.

48.

New inhaler devices - the good, the bad and the ugly.

Lavorini F, Fontana GA, Usmani OS.

Respiration. 2014;88(1):3-15. doi: 10.1159/000363390. Epub 2014 May 27. Review.

49.

Guidance on handheld inhalers in asthma and COPD guidelines.

Dekhuijzen PN, Bjermer L, Lavorini F, Ninane V, Molimard M, Haughney J.

Respir Med. 2014 May;108(5):694-700. doi: 10.1016/j.rmed.2014.02.013. Epub 2014 Mar 1. Review.

50.

Interstitial lung edema triggered by marathon running.

Zavorsky GS, Milne EN, Lavorini F, Rienzi JP, Lavin KM, Straub AM, Pistolesi M.

Respir Physiol Neurobiol. 2014 Jan 1;190:137-41. doi: 10.1016/j.resp.2013.10.007. Epub 2013 Oct 25.

PMID:
24369923

Supplemental Content

Loading ...
Support Center